Erica Fiorini May 12 Advancing Hedgehog Signaling Research Through Synthetic Biology by Erica Fiorini | May 12, 2026 238 Dr. Shixin Ye-Lehmann , Principal Investigator at INSERM U1195 (Diseases and Hormones of the Nervous System), Hôpital de Bicêtre, University Paris-Saclay, pioneers synthetic biology tools to address n... Read more > Company Blog May 12, 2026
Erica Fiorini Feb 03 Laying the Foundation: How a Complex Edit Unlocked a New Research Direction by Erica Fiorini | February 3, 2026 1971 The Human Embryonic Kidney 293T (HEK293T) cell line is a research staple, but for Dr. Marta Popović at the Ruđer Bošković Institute , it represented a critical bottleneck. Her lab was launching a stra... Read more > Company Blog Feb 3, 2026
Erica Fiorini Dec 15 Accelerating Adoptive Cell Therapy Development by Erica Fiorini | December 15, 2025 1383 Today, we feature Dr. Alessandro Penna from the University of Padova, whose research focuses on advancing adoptive cell therapies for prostate cancer. When standard gene-editing protocols failed to pr... Read more > Company Blog Dec 15, 2025
Erica Fiorini Sep 24 Cytosurge and Lexogen Announce First End-to-End Commercial Live-Cell Sequencing Workflow by Erica Fiorini | September 24, 2025 2020 Zürich, Switzerland, and Vienna, Austria – Sept. 24, 2025 – Cytosurge AG, a leader in single-cell manipulation technologies, and Lexogen, a pioneer in RNA sequencing solutions, today announced that th... Read more > Press Release Sep 24, 2025
Erica Fiorini Aug 04 Advancing Single-Cell Research by Erica Fiorini | August 4, 2025 1800 We recently had the opportunity to speak with two remarkable professionals from Institut Curie , France's leading cancer research center. Dr. Leanne de Koning, Project Manager of the Single Cell Initi... Read more > Company Blog FluidFM Applications Aug 4, 2025
Erica Fiorini Jul 21 Zhejiang University Landmark Discovery by Erica Fiorini | July 21, 2025 1923 Cancer immunotherapy has emerged as an effective strategy in oncology treatment. However, achieving localized, persistent immune stimulation at tumor sites while effectively counteracting the immunosu... Read more > Company Blog Jul 21, 2025
Erica Fiorini Jun 16 Turning CRISPR Challenges into Breakthroughs by Erica Fiorini | June 16, 2025 2742 Today, we are pleased to introduce Dr. Alfonso Calvo , a principal investigator at Cancer Center Clínica Universidad de Navarra (CCUN) in Spain. His research focuses on understanding how changes in th... Read more > Company Blog FluidFM Applications Jun 16, 2025
Erica Fiorini Apr 09 Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer by Erica Fiorini | April 9, 2025 4337 Zurich, Switzerland – April 9, 2025 – Cytosurge AG, a leading biotech company in single-cell manipulation and cell engineering solutions, announces the appointment of Magid Haddouchi, PhD, as its new ... Read more > Press Release Apr 9, 2025
Erica Fiorini Feb 05 Unlocking Spirostomum’s Secrets by Erica Fiorini | February 5, 2025 4204 Single-cell research has reached an exciting milestone with the successful biopsy of Spirostomum, a unique unicellular organism, using the FluidFM OMNIUM platform. This achievement demonstrates the ve... Read more > Company Blog FluidFM Applications Feb 5, 2025
Erica Fiorini Jan 20 Pushing New Frontiers in Malaria Research by Erica Fiorini | January 20, 2025 2668 In Rijswijk, the Netherlands, the Biomedical Primate Research Centre (BPRC) is making strides in infectious disease research. Recently, two of its scientists, Dr. Anne-Marie Zeeman and Dr. Annemarie M... Read more > Company Blog FluidFM Applications Jan 20, 2025
Erica Fiorini Jan 09 Cytosurge Announces Strategic Leadership Transition by Erica Fiorini | January 9, 2025 5075 Zürich, Switzerland – January 9, 2025 – Cytosurge AG, a leader in single-cell manipulation, a biotech company pioneering innovative single-cell biopsies and cell-line engineering solutions, announces ... Read more > Press Release Jan 9, 2025
Erica Fiorini Dec 17 Triple Hit From Peking University, China! by Erica Fiorini | December 17, 2024 4813 Recently, Peking University, Beijing, China, celebrated three major publications featuring FluidFM technology, listed below in chronological order: Quiescent cancer cells induced by high-density culti... Read more > Company Blog FluidFM Applications Dec 17, 2024
